In the patient group treated with hydroxychloroquine + azithromycin we expect to find a diminution of 20% or more regarding the evolution of acute respiratory syndrome, as opposed to patients who have not been treated with these medicines.
To date, there is no shown effective treatment regime for acute respiratory distress caused by COVID-19.
